Skip to main content
Retour
MANE logo

Veradermics, Incorporated

Qualité des données : 100%
Suracheté
MANE
NYSE Healthcare Biotechnology
65,56 €
▲ 2,07 € (3,26%)
Cap. Boursière : 2,30B
Fourchette du Jour
62,28 € 66,54 €
Fourchette 52 Semaines
32,00 € 66,54 €
Volume
428 108
Moyenne 50J / 200J
47,48 € / 47,48 €
Clôture Précédente
63,49 €

Quick Summary

Historique des Prix

Tendances Financières

Comparaison Sectorielle

vs médiane du secteur Healthcare (631 pairs)

Métrique Action Médiane du Secteur
P/E -86,8 0,2
P/B 42,1 3,0
ROE % -76,5 3,6
Net Margin % 3,8
Rev Growth 5Y % 9,7
D/E 0,0 0,2

Objectif de Cours des Analystes

Hold
75,00 € +14.4%
BPA Prévisionnel
-2,57 €
CA Est.
0,0

Estimations de Bénéfices

Période BPA Est. CA Est. Analystes
FY2028 -3,10 €
-5,10 € – -1,60 €
48,70M 3
FY2027 -2,59 €
-3,12 € – -2,00 €
10,39M 3
FY2026 -2,57 €
-2,79 € – -2,35 €
0,0 2

Earnings Surprises

Last 1 quarter
Quarter Est. EPS Actual EPS Surprise
2026-02-25 -0,92 € -1,63 € -76,5%

Dividend History

Yield

0,00%

Payout Ratio

0,00%

Growth (3Y)

N/A

Growth (5Y)

N/A

No dividend history available.

Points Clés

Debt/Equity of 0,00 — conservative balance sheet
Negative free cash flow of -23,69M

Croissance

Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Qualité

Return on Equity
-76,46%
ROIC-36,74%
Net MarginN/A
Op. MarginN/A

Sécurité

Debt / Equity
0,00
Current Ratio11,77
Interest Coverage-45,77

Valorisation

P/E Ratio
-86,82
Forward P/EN/A
P/B Ratio42,07
EV/EBITDAN/A
Dividend Yield0,00%

All Fundamental Metrics

Growth
Revenue Growth (1Y) N/A Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 0,0 Net Income (TTM) -26,49M
ROE -76,46% ROA -44,61%
Gross Margin N/A Operating Margin N/A
Net Margin N/A Free Cash Flow (TTM) -23,69M
ROIC -36,74% FCF Growth (3Y) N/A
Safety
Debt / Equity 0,00 Current Ratio 11,77
Interest Coverage -45,77
Dividends
Dividend Yield 0,00% Payout Ratio 0,00%
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -86,82 Forward P/E N/A
P/B Ratio 42,07 P/S Ratio N/A
PEG Ratio -4,04 Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -1,03%
Market Cap 2,30B Enterprise Value 2,25B

Income Statement

Annual, most recent first

Income statement data, annual, most recent first
Metric FY2024 FY2023
Revenue 0,0 0,0
Net Income -26,49M -16,49M
EPS (Diluted) -0,14 -0,08
Gross Profit 0,0 0,0
Operating Income -26,78M -17,32M

Balance Sheet

Annual, most recent first

Balance sheet data, annual, most recent first
Metric FY2024 FY2023
Total Assets 59,38M 18,46M
Total Liabilities 4,72M 3,84M
Shareholders' Equity 54,67M 14,62M
Total Debt 0,0 786 000,0
Cash & Equivalents 53,08M 16,30M
Current Assets 55,54M 17,56M
Current Liabilities 4,72M 3,05M